PubRank

Michel Panisset

Author PubWeight™ 26.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exome sequencing identifies FUS mutations as a cause of essential tremor. Am J Hum Genet 2012 2.30
2 Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 2004 2.02
3 Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009 1.42
4 Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov Disord 2012 1.29
5 Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Mov Disord 2006 1.14
6 Manganese cumulative exposure and symptoms: a follow-up study of alloy workers. Neurotoxicology 2008 1.06
7 Manganese neurotoxicity: behavioral, pathological, and biochemical effects following various routes of exposure. Rev Environ Health 2002 1.03
8 Salivary production in Parkinson's disease. Mov Disord 2005 1.00
9 REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep 2006 1.00
10 Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant. Neurotoxicology 2006 0.97
11 Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol 2010 0.96
12 Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease. Mov Disord 2009 0.94
13 Executive functions in frontotemporal dementia and Lewy body dementia. Neuropsychology 2009 0.89
14 The error negativity in nonmedicated and medicated patients with Parkinson's disease. Clin Neurophysiol 2007 0.88
15 Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort. Can J Neurol Sci 2011 0.87
16 Bradykinesia in patients with essential tremor. Brain Res 2006 0.85
17 Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation. Mov Disord 2007 0.85
18 The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson's disease. Exp Brain Res 2005 0.84
19 Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med 2013 0.82
20 Is there seasonal variation in risk of Parkinson's disease? Mov Disord 2007 0.82
21 The effect of Trager therapy on the level of evoked stretch responses in patients with Parkinson's disease and rigidity. J Manipulative Physiol Ther 2002 0.80
22 Subthalamic stimulation improves motor function but not home and neighborhood mobility. Mov Disord 2014 0.79
23 Chylomicron retention disease: dystonia as a new clinical feature. Mov Disord 2010 0.79
24 LINGO1 variants in the French-Canadian population. PLoS One 2011 0.77
25 The detection of tremor during slow alternating movements performed by patients with early Parkinson's disease. Exp Brain Res 2003 0.77
26 Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Arch Clin Neuropsychol 2008 0.76